Search

Sign in to unlock AI Chat and more features

Effect of Low Dose NOACS (Rivaroxaban 2.5 mg Twice Daily) on Patients Who Underwent Complex Percutaneous Coronary Intervention

Abstract
Background: Patients undergoing complex percutaneous coronary intervention (PCI) carry a higher incidence of in-stent restenosis. This could be due to late acquired malposition, ne-ointimal hyperplasia, increased coagulation activity, in patients having a higher incidence of coronary atherosclerosis, rupture plaque and acute coronary syndrome. Rivaroxiban, selectively targets activated factor X (X...
Subjects
Rivaroxaban
Percutaneous coronary intervention
Medicine
Internal medicine
Cardiology
Percutaneous
Anesthesia
Atrial fibrillation
Warfarin
Myocardial infarction
Sustainable Development Goals (SDG)
Good health and well-being


pdf file

Effect of Low Dose NOACS (Rivaroxaban 2.5 mg Twice Daily) on Patients Who Underwent Complex Percutaneous Coronary Intervention
pdf file

Effect of Low Dose NOACS (Rivaroxaban 2.5 mg Twice Daily) on Patients Who Underwent Complex Percutaneous Coronary Intervention

Abstract
Background: Patients undergoing complex percutaneous coronary intervention (PCI) carry a higher incidence of in-stent restenosis. This could be due to late acquired malposition, ne-ointimal hyperplasia, increased coagulation activity, in patients having a higher incidence of coronary atherosclerosis, rupture plaque and acute coronary syndrome. Rivaroxiban, selectively targets activated factor X (X...
Subjects
Rivaroxaban
Percutaneous coronary intervention
Medicine
Internal medicine
Cardiology
Percutaneous
Anesthesia
Atrial fibrillation
Warfarin
Myocardial infarction
Sustainable Development Goals (SDG)
Good health and well-being


pdf file